The Use of MiniMed780G System Is Associated With Stable Glycemic Control in People With Type 1 Diabetes Before, During, and After Ramadan: An Observational Study
Conclusion: The use of the MiniMed780G system is safe with favorable glycemic outcomes across nonfasting and fasting months.
Saved in:
Main Authors: | Abdullah M. Alguwaihes, Najla Alotaibi, Metib Alotaibi, Naglaa Masry, Saher Safarini |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/jdr/4144787 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real world efficacy and safety of the advanced hybrid closed-loop system MiniMed 780G (SmartGuard) in children under 7 years of age
by: Sara López-López, et al.
Published: (2025-01-01) -
Corrigendum to “Food Expenditure and Food Consumption before and during Ramadan in Moroccan Households”
by: Imane Barakat, et al.
Published: (2022-01-01) -
The Establishment of Ramadan Principality
by: Fatma Akkuş Yiğit
Published: (2013-12-01) -
Improving glycemic control by transitioning from the MiniMedTM 640G to 770G in Japanese adults with type 1 diabetes mellitus: a prospective, single-center, observational study
by: Satoshi Kubota, et al.
Published: (2024-10-01) -
Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitus
by: Toshiki Kogai, et al.
Published: (2025-02-01)